GenPath Oncology, a division of BioReference Health™, LLC is a leading expert in cancer diagnostics. GenPath offers a comprehensive test portfolio to provide a single-source solution laboratory to support the needs of healthcare providers and patients across all stages of cancer. Backed by a team of specialized board-certified pathologists, GenPath delivers a wide range of diagnostic oncology solutions, from routine clinical and special coagulation testing to complex genomic testing for tumor sequencing and hereditary cancer syndromes.
GenPath testing processes are overseen by specialized board-certified pathologists in gastroenterology, genitourinary, surgical pathology, hematopathology, dermatopathology, and cytology.
GenPath can perform a comprehensive work-up for patients with hematopathologic tumors as well as special coagulation issues.
OnkoSight AdvancedTM is a GenPath proprietary product line of Next-Generation Sequencing (NGS) assays for hematologic malignancies and solid tumors.
Minimal residual disease (MRD) detection allows further refinement and individualization of treatment strategies for cancer patients.